RxDoctor Payments Data

Steven Bailey, MD

Plastic and Reconstructive Surgery · Kennesaw, GANPI 1083818926

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (29.4%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 39 manufacturers reported payments, led by TELA Bio, Inc. at 35.4% of the total. Reporting peaked in 2020 at $4,441 and has fallen 92.8% since, to $320 in 2025.

$13,929in general payments, 2019–2025

Across 119 payments — averaging $117.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • TELA Bio, Inc.$5K
  • AbbVie$2K
  • Trimed, Inc.$2K
  • Abbott$1K
  • United Orthopedics LLC$1K
  • KCI USA, Inc.$705
  • plus $2K from 33 others

What the payments were for

  • Consulting fees$3,43325%
  • Travel & lodging$3,94828%
  • Food & beverage$4,09229%
  • Education$1,1068%
  • Gifts$1,35010%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,929 in reported general payments places this provider in the 80th percentile of 83 plastic and reconstructive surgery providers in Georgia.

See all plastic and reconstructive surgery providers in Georgia

Medicare billing

Part B allowed, 2024
$15,208
Medicare patients
19
Services billed
56

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen16$153

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Kennesaw

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →